Applied DNA Says Results From Animal Testing of Coronavirus DNA Vaccines 'Beyond Expectations'
Applied DNA Sciences Inc (NASDAQ: APDN) shares are rallying to a six-month high following an update from the company regarding its COVID-19 vaccine program.
